Nicholas Hart
Directeur Financier/CFO chez Alltracel Pharmaceuticals Plc
Profil
Nicholas Hart is Chief Financial Officer of Alltracel Pharmaceuticals Plc.
Prior to joining Alltracel Pharmaceuticals on May 09, 2007, he was Chief Financial Officer of Smart Holograms Ltd.
and Bioscience Managers Ltd.
as well as Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer of Cantab Pharmaceuticals Plc.
Previously, he worked at Ohmeda and Servier SAS.
Mr. Hart has over 20 years of experience in the life sciences sector.
Postes actifs de Nicholas Hart
| Sociétés | Poste | Début |
|---|---|---|
Alltracel Pharmaceuticals Plc
 Alltracel Pharmaceuticals Plc Miscellaneous Commercial ServicesCommercial Services Alltracel Pharmaceuticals Plc conducts biopharmaceutical research and development. The firm also markets toothbrushes and dental floss through Butler and Gum brands. It develops products for the wound care and dental care markets. The company was founded in 1996 by Anthony Richardson and Gerard Brandon and is headquartered in Sallynoggin, Ireland. | Directeur Financier/CFO | 09/05/2007 |
Anciens postes connus de Nicholas Hart
| Sociétés | Poste | Fin |
|---|---|---|
Ohmeda
 Ohmeda Pharmaceuticals: OtherHealth Technology Part of Atlas Copco AB, Ohmeda is a British company that manufactures equipment goods and gas pipeline systems. The company is based in Surrey, UK. Ohmeda was acquired by Atlas Copco Medical Ltd. on January 01, 1995 for $40.52 million. | Corporate Officer/Principal | - |
Cantab Pharmaceuticals Plc
 Cantab Pharmaceuticals Plc MiscellaneousMiscellaneous Cantab Pharmaceuticals plc, based in Cambridge, England, was established in 1989 to exploit advances in immunology. Since that time, Cantab has become a leader in the areas of immunotherapy and gene delivery and has developed a broad portfolio of novel products for the treatment and prevention of many chronic infectious diseases, cancer and substance addiction. | President | - |
Les Laboratoires Servier SAS
 Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Alltracel Pharmaceuticals Plc
Alltracel Pharmaceuticals Plc Miscellaneous Commercial ServicesCommercial Services Alltracel Pharmaceuticals Plc conducts biopharmaceutical research and development. The firm also markets toothbrushes and dental floss through Butler and Gum brands. It develops products for the wound care and dental care markets. The company was founded in 1996 by Anthony Richardson and Gerard Brandon and is headquartered in Sallynoggin, Ireland. | Commercial Services |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Health Technology |
Ohmeda
Ohmeda Pharmaceuticals: OtherHealth Technology Part of Atlas Copco AB, Ohmeda is a British company that manufactures equipment goods and gas pipeline systems. The company is based in Surrey, UK. Ohmeda was acquired by Atlas Copco Medical Ltd. on January 01, 1995 for $40.52 million. | Health Technology |
Cantab Pharmaceuticals Plc
Cantab Pharmaceuticals Plc MiscellaneousMiscellaneous Cantab Pharmaceuticals plc, based in Cambridge, England, was established in 1989 to exploit advances in immunology. Since that time, Cantab has become a leader in the areas of immunotherapy and gene delivery and has developed a broad portfolio of novel products for the treatment and prevention of many chronic infectious diseases, cancer and substance addiction. | Miscellaneous |
